The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids

No abstract is available for this paper.

• Publication year

  2005

• Venue

  AAPS Journal

• Publication date

  2005-10-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1208/aapsj070364PMID 16353941PMCID PMC2751266
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Medicinal Uses of Cannabis and Cannabinoids

  2008cited by this paper
• Cannabinoids and Multiple Sclerosis

  2007cited by this paper
• Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis

  2005cited by this paper
• CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition

  2005cited by this paper
• Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

  2005cited by this paper
• Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors

  2005cited by this paper
• Pharmacological actions of cannabinoids.

  2005cited by this paper
• Effects of cannabinoids on neurotransmission.

  2005cited by this paper
• Regulation of food intake by oleoylethanolamide

  2005cited by this paper
• A Glial Endogenous Cannabinoid System Is Upregulated in the Brains of Macaques with Simian Immunodeficiency Virus-Induced Encephalitis

  2005cited by this paper
• Effects on the immune system.

  2005cited by this paper
• Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism.

  2005cited by this paper
• Cannabinoid tolerance and dependence.

  2005cited by this paper
• Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor.

  2005cited by this paper
• Cannabinoid mechanisms of pain suppression.

  2005cited by this paper
• The biosynthesis, fate and pharmacological properties of endocannabinoids.

  2005cited by this paper
• Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.

  2005cited by this paper
• Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation

  2005cited by this paper
• Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.

  2005cited by this paper
• CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition.

  2005cited by this paper
• Human studies of cannabinoids and medicinal cannabis.

  2005cited by this paper
• Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats.

  2005cited by this paper
• Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

  2005cited by this paper
• An endocannabinoid mechanism for stress-induced analgesia

  2005cited by this paper
• levated Levels of Endocannabinoids and CB1 eceptor-Mediated G-Protein Signaling in the refrontal Cortex of Alcoholic Suicide Victims

  2005cited by this paper
• Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility.

  2005cited by this paper
• Modulators of endocannabinoid enzymic hydrolysis and membrane transport.

  2005cited by this paper
• Effects on cell viability.

  2005cited by this paper
• Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

  2005cited by this paper
• Inhibition of restraint stress‐induced neural and behavioural activation by endogenous cannabinoid signalling

  2005cited by this paper
• Cannabinoids and the digestive tract.

  2005cited by this paper
• Antifibrogenic role of the cannabinoid receptor CB2 in the liver.

  2005cited by this paper
• Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress

  2005cited by this paper
• 2-Arachidonoylglycerol Increases in Ischemia–Reperfusion Injury of the Rat Liver

  2005cited by this paper
• Allosteric Modulation of the Cannabinoid CB1 Receptor

  2005cited by this paper
• Retrograde signalling by endocannabinoids.

  2005cited by this paper
• CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.

  2005cited by this paper
• Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors

  2005cited by this paper
• Cannabinoid receptor as a novel target for the treatment of prostate cancer.

  2005cited by this paper
• Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

  2005cited by this paper
• Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non‐tumour brain tissue

  2005cited by this paper
• Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

  2005cited by this paper
• The expanding field of cannabimimetic and related lipid mediators

  2005cited by this paper
• Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor‐mediated phenotypic hypoalgesia

  2004cited by this paper
• Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.

  2004cited by this paper
• Influence of adrenomedullin on tone of isolated bovine retinal arteries.

  2004cited by this paper
• The medicinal use of cannabis in the UK: results of a nationwide survey

  2004cited by this paper
• Novel Pharmacological Targets for Cannabinoids

  2004cited by this paper
• 2-Arachidonoylglycerol

  2004cited by this paper
• Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.

  2004cited by this paper
• Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

  2004cited by this paper
• Functional disassociation of the central and peripheral fatty acid amide signaling systems.

  2004cited by this paper
• Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims

  2004cited by this paper
• Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors

  2004cited by this paper
• The endogenous cannabinoid system protects against colonic inflammation.

  2004cited by this paper
• Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

  2004cited by this paper
• Segregation of two endocannabinoid‐hydrolyzing enzymes into pre‐ and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala

  2004cited by this paper
• 3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects

  2004cited by this paper
• Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity

  2004cited by this paper
• Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin

  2004cited by this paper
• Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension

  2004cited by this paper
• SPECIFIC CB2 RECEPTOR AGONIST SUPPRESSES THE MURINE MODEL OF EXPERIMENTAL AUTOIMMUNE UVEITIS

  2004cited by this paper
• Modulation of trigeminal sensory neuron activity by the dual cannabinoid–vanilloid agonists anandamide, N‐arachidonoyl‐dopamine and arachidonyl‐2‐chloroethylamide

  2004cited by this paper
• Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development

  2004cited by this paper
• Cannabinoid agonists in the treatment of blepharospasm--a case report study.

  2004cited by this paper
• Effects on turning of microinjections into basal ganglia of D(1) and D(2) dopamine receptors agonists and the cannabinoid CB(1) antagonist SR141716A in a rat Parkinson's model.

  2004cited by this paper
• Characterization of an anandamide degradation system in prostate epithelial PC‐3 cells: synthesis of new transporter inhibitors as tools for this study

  2004cited by this paper
• Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

  2004cited by this paper
• The cannabinomimetic arachidonyl‐2‐chloroethylamide (ACEA) acts on capsaicin‐sensitive TRPV1 receptors but not cannabinoid receptors in rat joints

  2004cited by this paper
• Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice.

  2004cited by this paper
• An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

  2004cited by this paper
• Anandamide-Evoked Activation of Vanilloid Receptor 1 Contributes to the Development of Bladder Hyperreflexia and Nociceptive Transmission to Spinal Dorsal Horn Neurons in Cystitis

  2004cited by this paper
• Synergistic interactions between cannabinoid and opioid analgesics.

  2004cited by this paper
• The endogenous cannabinoid system and its role in nociceptive behavior.

  2004cited by this paper
• Endocannabinoids accumulate in spinal cord of SOD1G93A transgenic mice

  2004cited by this paper
• Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia.

  2004cited by this paper
• Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis

  2004cited by this paper
• Enhanced anandamide degradation is associated with neuronal apoptosis induced by the HIV‐1 coat glycoprotein gp120 in the rat neocortex

  2004cited by this paper
• In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.

  2004cited by this paper
• Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies

  2004cited by this paper
• Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

  2004cited by this paper
• RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol

  2004cited by this paper
• Endogenous Cannabinoids are Candidates for Lipid Mediators of Bone Cement Implantation Syndrome

  2004cited by this paper
• Experimental Parkinsonism Alters Anandamide Precursor Synthesis, and Functional Deficits are Improved by AM404: A Modulator of Endocannabinoid Function

  2004cited by this paper
• Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.

  2004cited by this paper
• A new strategy to block tumor growth by inhibiting endocannabinoid inactivation

  2004cited by this paper
• Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo

  2004cited by this paper
• Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer's Disease Brains

  2003cited by this paper
• Cannabinoids: potential anticancer agents

  2003cited by this paper
• A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

  2003cited by this paper
• Statins stimulate arachidonic acid release and prostaglandin I2 production in rat liver cells

  2003cited by this paper
• Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

  2003cited by this paper
• The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.

  2003cited by this paper
• Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.

  2003cited by this paper
• Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors

  2003cited by this paper
• An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice.

  2003cited by this paper
• CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity

  2003cited by this paper
• Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism

  2003cited by this paper
• Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.

  2003cited by this paper
• Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

  2003cited by this paper

• Cannabinoids, Oxidative Stress and Female Reproduction: Where do we stand?

  2025cites this paper
• Molecular Mechanisms of the Endocannabinoid System with a Focus on Reproductive Physiology and the Cannabinoid Impact on Fertility

  2025cites this paper
• Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

  2024cites this paper
• Effects of Cannabinoids on Intestinal Motility, Barrier Permeability, and Therapeutic Potential in Gastrointestinal Diseases

  2024cites this paper
• Decoding the Therapeutic Potential of Cannabis and Cannabinoids in Neurological Disorders.

  2024cites this paper
• Beneficial effects of cannabidiol from Cannabis

  2024cites this paper
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality

  2024cites this paper
• LY-2183240 enhances reward-seeking behavior with inducing neuronal excitation and early apoptosis in mouse

  2024cites this paper
• Integrative approach to the therapeutic use of cannabis for orofacial pain

  2023cites this paper
• Cannabinoids: Emerging sleep modulator.

  2023cites this paper
• Cannabinoids as multifaceted compounds.

  2023cites this paper
• Antibacterial and Analgesic Properties of Beta-Caryophyllene in a Murine Urinary Tract Infection Model

  2023cites this paper
• Unravelling a novel role for Cannabidivarin in the modulation of subventricular zone postnatal neurogenesis

  2023cites this paper
• Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery

  2022cites this paper
• A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects

  2022cites this paper
• Overview of the Endocannabinoid System and Endocannabinoidome

  2022cites this paper
• The mystery behind the apprehensions of the selective cannabinoid receptor type-2 agonist BZO-HEXOXIZID (MDA-19) as a drug of abuse

  2022cites this paper
• Protein-protein allosteric effects on cannabinoid receptor heteromer signaling

  2022cites this paper
• SAR study on Novel truxillic acid monoester-Based inhibitors of fatty acid binding proteins as Next-Generation antinociceptive agents.

  2022cites this paper
• USE OF CANNABIDIOL PRODUCTS BY PET OWNERS IN SLOVENIA: A SURVEY-BASED STUDY

  2022cites this paper
• Pharmacological Treatment of Fibromyalgia

  2021cites this paper
• Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by Cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide.

  2021cites this paper
• The Endocannabinoid System

  2021cites this paper
• In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography.

  2021cites this paper
• The rich pharmacological activities of Magnolia officinalis and secondary effects based on significant intestinal contributions.

  2021cites this paper
• Current review of hemp-based medicines in dogs.

  2021cites this paper
• Delayed on- and off-retinal responses of cones pathways in regular cannabis users: An On-Off flash electroretinogram case-control study.

  2021cites this paper
• Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?

  2021cites this paper
• Endocannabinoids in immune regulation and immunopathologies

  2021cites this paper
• Cannabinoid Receptor 1 and 2 Signaling Pathways Involved in Sepsis

  2021cites this paper
• The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

  2021cites this paper
• Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models.

  2020cites this paper
• Pharmacology of Endocannabinoids and Their Receptors

  2020cites this paper
• Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning

  2020cites this paper
• Cannabis Constituents and Acetylcholinesterase Interaction: Molecular Docking, In Vitro Studies and Association with CNR1 rs806368 and ACHE rs17228602

  2020cites this paper
• Cannabis Effect on Female Reproductive Health

  2020cites this paper
• Non-opioid Analgesics and the Endocannabinoid System

  2020cites this paper
• The 90th Birthday of Professor Raphael Mechoulam, a Top Cannabinoid Scientist and Pioneer

  2020cites this paper
• Inhibited TLR-4/NF- κB Pathway Mediated by Cannabinoid Receptor 2 Activation Curbs Ongoing Liver Fibrosis in Bile Duct Ligated Rats

  2020cites this paper
• technical report on the new psychoactive substance methyl 2-{ [ 1-( 4-fluorobutyl )-1 H-indole-3-carbonyl ] amino }-3 , 3-dimethylbutanoate ( 4 F-MDMB-BICA )

  2020cites this paper
• Electroacupuncture increases immunoexpression of CB1 and CB2 receptors in experimental model of inflammatory bone loss.

  2019cites this paper
• Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1

  2019cites this paper
• In vivo evaluation of the CB1 allosteric modulator LDK1258 reveals CB1-receptor independent behavioral effects.

  2019cites this paper
• Pharmacologic targeting of the CB2 cannabinoid receptor for application in centrally-mediated chronic pain

  2019cites this paper
• Neurological Aspects of THC as a Treatment for Generalized Anxiety

  2019cites this paper
• Diarylureas Containing 5-Membered Heterocycles as CB1 Receptor Allosteric Modulators: Design, Synthesis, and Pharmacological Evaluation.

  2018cites this paper
• Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.

  2018cites this paper
• Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats

  2018cites this paper
• Inhibition of fatty acid amide hydrolase in the insular cortex produces analgesic effects in neuropathic rats

  2018cites this paper
• Characterising the anti-convulsant effects of CBD and CBDV on layer II of the medial entorhinal cortex of rat and human brain tissue in vitro

  2018influential citation
• Endocannabinoids in Body Weight Control

  2018cites this paper
• Unveiling the role of adenosine A2A receptors on neurogenesis induced by activation of cannabinoid receptors in rat SVZ and DG stem/progenitor cell cultures

  2018cites this paper
• Efficacy and Safety Profile of Cannabinoid-targeted Compounds for Seizure Control in Immature Animals

  2018cites this paper
• Modulation of central endocannabinoid system results in gastric mucosal protection in the rat.

  2018cites this paper
• Chronic Cannabis-induced oxidative stress and reproductive containment in female mice

  2018cites this paper
• Enhanced endocannabinoid tone as a potential target of pharmacotherapy

  2018cites this paper
• Peripheral modulation of the endocannabinoid system in metabolic disease.

  2018cites this paper
• Report on the risk assessment of N-(1- amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3- carboxamide in the framework of the Council Decision on new psychoactive substances

  2018cites this paper
• Long-term hypophagic effect of chronic cannabis (Δ9-THC) administration on body weight progress investigated in a rat model

  2017cites this paper
• Bell control of mitochondrial function Endocannabinoids in neuroendopsychology : multiphasic

  2017cites this paper
• Cannabinoids for the treatment of dementia.

  2017cites this paper
• Anticonvulsant effect of cannabinoid receptor agonists in models of seizures in developing rats

  2017cites this paper
• The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice

  2017cites this paper
• Synthesis of N-acyl derivatives of Pro-Gly-Pro-Leu peptide: Proteolytic stability in vitro and effects on mouse macrophage cells RAW264.7

  2017cites this paper
• Novel Diarylurea Based Allosteric Modulators of the Cannabinoid CB1 Receptor: Evaluation of Importance of 6-Pyrrolidinylpyridinyl Substitution.

  2017cites this paper
• Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging

  2016cites this paper
• Progress in study of Cannabis sativa leaves extracts without psychotropic cannabinoids in animal model of neuropathic pain

  2016cites this paper
• PLANEJAMENTO, DESENHO, AVALIAÇÃO TOXICOLÓGICA E DOCKING MOLECULAR DE UMA NOVA SÉRIE DE INIBIDORES DA ENZIMA FAAH

  2016cites this paper
• Seeing over the horizon – targeting the endocannabinoid system for the treatment of ocular disease

  2016cites this paper
• The use of cannabinoids in animals and therapeutic implications for veterinary medicine: a review

  2016cites this paper
• Cannabinoid receptors in the kidney

  2016cites this paper
• Endocannabinoid System: A Multi-Facet Therapeutic Target.

  2016cites this paper
• Role of Cannabinoids in Gastrointestinal Mucosal Defense and Inflammation

  2016cites this paper
• Syntheses and Evaluation of Novel Cannabinoid Type 2 Receptors Tracers for PET Imaging

  2015cites this paper
• Cannabinoids in Late-Onset Alzheimer's

  2015cites this paper
• Cannabis and Bioactive Cannabinoids

  2015cites this paper
• Biosynthesis and Fate of Endocannabinoids.

  2015cites this paper
• A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects

  2015cites this paper
• Syntheses and Evaluation of Novel Cannabinoid Type 2 Receptors Tracers for PET Imaging

  2015cites this paper
• Regulation of inflammation by cannabinoids, the endocannabinoids 2‐arachidonoyl‐glycerol and arachidonoyl‐ethanolamide, and their metabolites

  2015cites this paper
• Structure-activity relationships of substituted 1H-indole-2-carboxamides as CB1 receptor allosteric modulators.

  2015cites this paper
• Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor

  2015cites this paper
• Cannabinoids in late‐onset Alzheimer's disease

  2015cites this paper
• Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

  2015cites this paper
• Remote Neurodegeneration: Multiple Actors for One Play

  2014cites this paper
• Rôle et implication du système cannabinoïde dans la modulation périphérique de la douleur inflammatoire et neuropathique

  2014cites this paper
• Early phytocannabinoid chemistry to endocannabinoids and beyond

  2014cites this paper
• Cannabinoids, eating behaviour, and energy homeostasis.

  2014cites this paper
• Arrestins - Pharmacology and Therapeutic Potential

  2014cites this paper
• The role of Endocannabinoid System in pathogenesis and therapy of obesity

  2014cites this paper
• Les représentations des médecins généralistes concernant le cannabis, l'acool et le tabac. Enquête prospective auprès de 2186 médecins généralistes libéraux lorrains

  2014cites this paper
• 1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.

  2014cites this paper
• Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.

  2014cites this paper
• Prospective therapeutic agents for obesity: molecular modification approaches of centrally and peripherally acting selective cannabinoid 1 receptor antagonists.

  2014cites this paper
• Anandamide in primary sensory neurons: too much of a good thing?

  2014cites this paper
• Bicyclic imidazole-4-one derivatives: a new class of antagonists for the orphan G protein-coupled receptors GPR18 and GPR55

  2014cites this paper
• β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.

  2014cites this paper
• Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure–Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1)

  2014cites this paper
• Antagonists for the orphan G-protein-coupled receptor GPR55 based on a coumarin scaffold.

  2013cites this paper
• Macamides and their synthetic analogs: evaluation of in vitro FAAH inhibition.

  2013cites this paper